Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Reported Financial Results For 3Q2015, Cut Down Work Force By 60%

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) announced financial results for the recently concluded 3Q2015. As per the reports, the biggest highlight was its announcement to fire almost 60% of its full-time employees due to revenue pressure. Insights of The Matter Going forward, not more than 33 full-time employees will work for Synta Pharmaceuticals. As a result of […]

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) CEO Steps Down After Less Than A Year, Leaving A Biotech On The Mend

Anne Whitaker is stepped down as CEO of Synta Pharmaceuticals Corp. (NASDAQ:SNTA) just nine months after she got the position. Whitaker left the company in a state of disarray as the company tries to cut down its operations to limit losses. The former CEO joined Synta less than a year ago after leaving Sanofi SA […]

Wall Street Breakfast: Vermillion, Inc. (NASDAQ:VRML), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Herman Miller, Inc. (NASDAQ:MLHR)

Boston, MA 03/21/2014 (wallstreetpr) –Vermillion, Inc. (NASDAQ:VRML) had an attractive trading day Thursday. The company witnessed its shares jumping 6.05 percent to $2.98 by bell time. That gain came on solid volume of shares too, where almost three times the normal volume was traded. The shares changed hands between $2.78 and $3.06 on the day, […]

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Shows Promise With Anti-Cancer Drug

Boston, MA 10/29/2013 (wallstreetpr) – Shares of Synta Pharmaceuticals Corp. (NASDAQ:SNTA) plummeted to as low as $5.10 hours after the USA-based drug manufacturer presented positive one-year follow-up results from its GALAXY-1 trial of its ambitious anti-cancer innovation Ganetespib at the 15th World Conference on Lung Cancer (WCLC) in Sydney, Australia. GALAXY-1 is Synta Pharmaceutical’s (Synta) ambitious global, […]

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Shares Up by 5%

Boston, MA 10/11/2013 (wallstreetpr) – Synta Pharmaceuticals Corp. (NASDAQ:SNTA) share price shot up by close to 5% during single day of trading on October 10. It was trading at $6.43 per share on October 10 close of business as against a previous day close of $6.12. While the valuation went up the stock did not see […]